Treating Obesity in Preschoolers: A Review and Recommendations for Addressing Critical Gaps

Elizabeth K Towner1, Lisa M Clifford2, Mary Beth McCullough3

  • 1Department of Family Medicine and Public Health Sciences, Wayne State University School of Medicine, Wayne State University, IBio 6135 Woodward Avenue, H206, Detroit, MI 48202, USA.

Insights

Intensive interventions show promise for preschool obesity reduction. Addressing gaps in reach, evidence, and effectiveness measurement is crucial for advancing early childhood obesity research and interventions.

Area of Science:

  • Pediatric obesity research
  • Early childhood intervention science

Background:

  • Preschool obesity is an emerging public health concern.
  • Intensive, multicomponent interventions are a promising strategy for obesity reduction in young children.
  • Current interventions face challenges in reaching diverse populations and establishing clear effectiveness.

Purpose of the Study:

  • To review and discuss critical gaps in preschool obesity intervention research.
  • To identify approaches for improving intervention reach, evidence base, and effectiveness measurement.
  • To guide future research and practice in early childhood obesity prevention.

Main Methods:

  • Systematic literature review of preschool obesity interventions.
  • Analysis of intervention components, reach, and effectiveness metrics.
  • Identification of key challenges and proposed solutions.

Main Results:

  • Three critical gaps identified: poor reach to low-income/minority families, insufficient evidence on effective components, and lack of consensus on effectiveness measurement.
  • Multicomponent interventions show potential but require refinement.
  • Need for standardized outcome measures and broader accessibility.

Conclusions:

  • Advancing preschool obesity interventions requires addressing disparities in reach.
  • Further research is needed to determine the most effective and efficient treatment strategies.
  • Establishing consensus on measuring intervention effectiveness is vital for progress.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
332
Operant Conditioning Intervention01:24

Operant Conditioning Intervention

Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
619
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
358
Binge Eating Disorders01:23

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
702
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
269